Sagar Lonial's most recent trade in TG Therapeutics Inc was a trade of 5,000 Common Stock done at an average price of $30.4 . Disclosure was reported to the exchange on Nov. 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TG Therapeutics Inc | Sagar Lonial | Director | Sale of securities on an exchange or to another person at price $ 30.44 per share. | 11 Nov 2024 | 5,000 | 100,195 (0%) | 0% | 30.4 | 152,200 | Common Stock |
TG Therapeutics Inc | Sagar Lonial | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 22,250 | 121,543 (0%) | 0% | 0 | Common Stock | |
TG Therapeutics Inc | Sagar Lonial | Director | Sale of securities on an exchange or to another person at price $ 16.87 per share. | 17 Jun 2024 | 16,348 | 105,195 (0%) | 0% | 16.9 | 275,791 | Common Stock |
TG Therapeutics Inc | Sagar Lonial | Director | Sale of securities on an exchange or to another person at price $ 16.39 per share. | 17 Jun 2024 | 9,585 | 99,293 (0%) | 0% | 16.4 | 157,098 | Common Stock |
TG Therapeutics Inc | Sagar Lonial | Director | Sale of securities on an exchange or to another person at price $ 15.94 per share. | 13 Mar 2024 | 5,000 | 108,878 (0%) | 0% | 15.9 | 79,675 | Common Stock |
TG Therapeutics Inc | Sagar Lonial | Director | Sale of securities on an exchange or to another person at price $ 23.37 per share. | 23 Jun 2023 | 34,854 | 93,878 (0%) | 0% | 23.4 | 814,538 | COMMON STOCK |
TG Therapeutics Inc | Sagar Lonial | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 65,000 | 65,000 (0%) | 0% | 0 | COMMON STOCK |